FEB 24, 2020 6:01 AM PST

Nanoparticles provide momentum for better diagnostic imaging

WRITTEN BY: Tara Fernandez

Photoacoustic imaging is an emerging tool with a vast array of biomedical applications ranging from the detection of brain lesions to imaging early signs of breast cancer. This technique leverages the imaging capacities of both light excitation and ultrasound wave detection to enable noninvasive, high-resolution imaging of tissue and organ systems within the body.

This translates to a physician being empowered with the ability to monitor, in real-time, oxygen saturation in the blood, the distribution of specific molecular biomarkers in a tumor or how a drug is being absorbed in the body of a patient after injection.

How does photoacoustic imaging work? First, pulsating laser light is applied to the part of the body to be imaged. This light is absorbed by the tissue, causing acoustic waves to be generated. These are then detected to image select biological processes occurring several centimeters beneath the surface of the skin. Contrast agents introduced systemically can drastically improve the resolution and specificity of the images captured in the area of interest.

A recent study published in WIREs Nanomedicine and Nanobiotechnology describes advancements and challenges associated with the use of different photoacoustic imaging contrast agents for medical and research applications.

Authors and imaging experts Paul Kumar Upputuri and Manojit Pramanik from the School of Chemical and Biomedical Engineering at Singapore’s Nanyang Technological University provided their insights on trends in the field. 

To harness the full potential of photoacoustic imaging as a medical diagnostic platform, the clear resolution of the underlying tissue architecture is paramount. Improving this resolution is a major focus for scientists who are hoping to establish photoacoustic imaging as a widely-used diagnostic technique.

This is where nanoparticles can help. Researchers and diagnostic imagers currently have access to a toolbox of nanoparticle contrast agents including carbon nanotubes, bismuth selenide nanoplates and silver nanostructures. While such nanoparticles may possess excellent optical properties, administering them into the bloodstream of patients is not always feasible.

The next phase in the evolution of this technology will see the development of more biocompatible and biodegradable contrast nanoagents, with better safety profiles for routine internal use.

“Recent progress in the field of biodegradable and metabolizable nanoparticles with potential use in clinical applications makes us hopeful that soon these nanoagents will be traveling inside our body to reveal more than what we can see at present,” says Pramanik.


 

 

Sources: Advanced Science News, WIREs Nanomedicine and Nanobiotechnology.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
OCT 19, 2020
Clinical & Molecular DX
Making Capillary Electrophoresis Accessible for Any Lab
OCT 19, 2020
Making Capillary Electrophoresis Accessible for Any Lab
Analyzing nucleic acids through gel electrophoresis has been a staple of genetic research for decades. But using traditi ...
NOV 06, 2020
Clinical & Molecular DX
Your Earwax Says You're Depressed
NOV 06, 2020
Your Earwax Says You're Depressed
Cortisol, commonly known as the “stress hormone”, is the body’s built-in alarm system that sends siren ...
NOV 11, 2020
Clinical & Molecular DX
Smart Mask Detects COVID Infections, Sends Alert to Phone
NOV 11, 2020
Smart Mask Detects COVID Infections, Sends Alert to Phone
  This week, the Centers for Disease Control and Prevention issued new guidance to put the “mask debate&rdquo ...
NOV 12, 2020
Clinical & Molecular DX
Study Shows 1 in 5 COVID Tests Are False Positives
NOV 12, 2020
Study Shows 1 in 5 COVID Tests Are False Positives
  A study published in The BMJ has brought to light that the rapid finger-prick COVID-19 test may not be quite as r ...
DEC 15, 2020
Clinical & Molecular DX
Who Should Get the COVID Vaccine First?
DEC 15, 2020
Who Should Get the COVID Vaccine First?
Drug developers’ frantic hunt for vaccines against SARS-CoV-2 has finally begun to bear fruit, with several vaccin ...
Loading Comments...